menu

Joint Research Management Office

Performing research menu

SOP 26b

SOP 26b - Pharmacovigilance and safety reporting for sponsored non-CTIMPs [PDF 92KB]

 

This SOP is currently under review by the JRMO. Please note the JRMO have agreed that point 9 is inaccurate and will be amended.  

  • With immediate effect the sponsor must review the draft APR prior to REC/HRA submission.

 


Please note that the correct email address for reporting safety matters is now research.safety@qmul.ac.uk 

 

 

Return to top